A phase I study of VB6-845d
Latest Information Update: 30 Mar 2023
At a glance
- Drugs Citatuzumab bogatox (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 07 Mar 2023 According to a Carisma Therapeutics media release, Carisma Therapeutics merged with the Sesen Bio. The combined companies are named as Carisma Therapeutics.
- 16 May 2018 According to a Sesen Bio media release, Eleven Biotherapeutics changed its name to Sesen Bio.
- 23 Aug 2017 New trial record